These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 2202667)

  • 21. Performance of nuclear matrix protein 22 urine marker and voided urine cytology in the detection of urinary bladder tumors.
    Smrkolj T; Mihelič M; Sedlar A; Sterle I; Osredkar J; Sedmak B
    Clin Chem Lab Med; 2011 Feb; 49(2):311-6. PubMed ID: 21118051
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fluorescence in situ hybridization performed on exfoliated urothelial cells in patients with transitional cell carcinoma of the bladder.
    Degtyar P; Neulander E; Zirkin H; Yusim I; Douvdevani A; Mermershtain W; Kaneti J; Manor E
    Urology; 2004 Feb; 63(2):398-401. PubMed ID: 14972510
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of urinary cytology and urinary deoxyribonucleic acid flow cytometry in the diagnosis of bladder cancer.
    Pu YS; Tsai TC; Hsieh TS; Huang HH; Kuo SH; Hsueh WC
    J Formos Med Assoc; 1994 Mar; 93(3):216-21. PubMed ID: 7920061
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Combined morphologic and fluorescence in situ hybridization analysis of voided urine samples for the detection and follow-up of bladder cancer in patients with benign urine cytology.
    Daniely M; Rona R; Kaplan T; Olsfanger S; Elboim L; Freiberger A; Lew S; Leibovitch I
    Cancer; 2007 Dec; 111(6):517-24. PubMed ID: 17963263
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Routine follow-up cystoscopy in detection of recurrence in patients being monitored for bladder cancer.
    Raitanen MP; Leppilahti M; Tuhkanen K; Forssel T; Nylund P; Tammela T;
    Ann Chir Gynaecol; 2001; 90(4):261-5. PubMed ID: 11820414
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Is the performance of urinary cytology as high as reported historically? A contemporary analysis in the detection and surveillance of bladder cancer.
    Yafi FA; Brimo F; Auger M; Aprikian A; Tanguay S; Kassouf W
    Urol Oncol; 2014 Jan; 32(1):27.e1-6. PubMed ID: 23410943
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Voided urinary cytology in bladder cancer: is it time to review the indications?
    Talwar R; Sinha T; Karan SC; Doddamani D; Sandhu A; Sethi GS; Srivastava A; Narang V; Agarwal A; Adhlakha N
    Urology; 2007 Aug; 70(2):267-71. PubMed ID: 17826487
    [TBL] [Abstract][Full Text] [Related]  

  • 28. uCyt+/ImmunoCyt and cytology in the detection of urothelial carcinoma: an update on 7422 analyses.
    Comploj E; Mian C; Ambrosini-Spaltro A; Dechet C; Palermo S; Trenti E; Lodde M; Horninger W; Pycha A
    Cancer Cytopathol; 2013 Jul; 121(7):392-7. PubMed ID: 23495066
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Urinary bladder tumors studied by cystosonography. Part II: Staging.
    Abu-Yousef MM; Narayana AS; Brown RC; Franken EA
    Radiology; 1984 Oct; 153(1):227-31. PubMed ID: 6473786
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Intravesical echography. II. Staging].
    Passas J; Espuela R; Leiva O; Calahorra J; de la Rosa F; Borobia V
    Arch Esp Urol; 1990; 43 Suppl 1():35-47. PubMed ID: 2078067
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effects of the current World Health Organization/International Society of Urologic Pathologists bladder neoplasm classification system on urine cytology results.
    Curry JL; Wojcik EM
    Cancer; 2002 Jun; 96(3):140-5. PubMed ID: 12115301
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical significance of immediate urine cytology after transurethral resection of bladder tumor in patients with non-muscle invasive bladder cancer.
    Shin YS; Kim SD; Cha JS; Kim MK; Jeong YB; Kim HJ
    Int J Urol; 2011 Jun; 18(6):439-43. PubMed ID: 21481014
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of fluorescence in situ hybridization assay for surveillance of non-muscle invasive bladder cancer.
    Karnwal A; Venegas R; Shuch B; Bassett J; Rajfer J; Reznichek R
    Can J Urol; 2010 Apr; 17(2):5077-81. PubMed ID: 20398445
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Predictive value of urinary cytology in the diagnosis of urothelial tumors].
    Benizri E; Volpe P; Bastéris B; Poisson J; Chevallier D; Peyrottes A; Colomb F; Amiel J; Kermarec J; Toubol J
    J Urol (Paris); 1995; 101(2):77-9. PubMed ID: 8522858
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Urinary bladder tumors studied by cystosonography. Part I: Detection.
    Abu-Yousef MM; Narayana AS; Franken EA; Brown RC
    Radiology; 1984 Oct; 153(1):223-6. PubMed ID: 6473785
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diagnostic evaluation of apoptosis inhibitory gene and tissue inhibitor matrix metalloproteinase-2 in patients with bladder cancer.
    Eissa S; Shabayek MI; Ismail MF; El-Allawy RM; Hamdy MA
    IUBMB Life; 2010 May; 62(5):394-9. PubMed ID: 20408180
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nuclear matrix protein 22 as adjunct to urine cytology and cystoscopy in follow-up of superficial TCC of urinary bladder.
    Gupta NP; Sharma N; Kumar R
    Urology; 2009 Mar; 73(3):592-6; discussion 596-7. PubMed ID: 19168205
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinically unconfirmed positive urinary cytology: diagnostic implications and oncological outcomes.
    Aharony S; Baniel J; Yossepowitch O
    BJU Int; 2011 Oct; 108(8 Pt 2):E179-83. PubMed ID: 21615850
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Urinary cytology has a poor performance for predicting invasive or high-grade upper-tract urothelial carcinoma.
    Messer J; Shariat SF; Brien JC; Herman MP; Ng CK; Scherr DS; Scoll B; Uzzo RG; Wille M; Eggener SE; Steinberg G; Terrell JD; Lucas SM; Lotan Y; Boorjian SA; Raman JD
    BJU Int; 2011 Sep; 108(5):701-5. PubMed ID: 21320275
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Noninvasive detection of alterations in chromosome numbers in urinary bladder cancer cells, using fluorescence in situ hybridization.
    Okamura T; Umemoto Y; Yasui T; Saiki S; Kuroda H; Kotoh S; Kamizaki H
    Int J Clin Oncol; 2004 Oct; 9(5):373-7. PubMed ID: 15549587
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.